000			01914 a2200481 4500
005			20250514195206.0
264		0	_c20041220
008			200412s 0 0 eng d
022			_a0954-7894
024	7		_a10.1111/j.1365-2222.2004.02023.x _2doi
040			_aNLM _beng _cNLM
100	1		_aQuarcoo, D
245	0	0	_aResiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. _h[electronic resource]
260			_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _cAug 2004
300			_a1314-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAllergens _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBronchi _ximmunology
650	0	4	_aBronchial Hyperreactivity _ximmunology
650	0	4	_aBronchoalveolar Lavage Fluid _xcytology
650	0	4	_aFemale
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aInterferon-gamma _ximmunology
650	0	4	_aInterleukin-12 _ximmunology
650	0	4	_aInterleukin-4 _ximmunology
650	0	4	_aInterleukin-5 _ximmunology
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aOvalbumin _xpharmacology
650	0	4	_aTh2 Cells _ximmunology
700	1		_aWeixler, S
700	1		_aJoachim, R A
700	1		_aStock, P
700	1		_aKallinich, T
700	1		_aAhrens, B
700	1		_aHamelmann, E
773	0		_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 34 _gno. 8 _gp. 1314-20
856	4	0	_uhttps://doi.org/10.1111/j.1365-2222.2004.02023.x _zAvailable from publisher's website
999			_c14998394 _d14998394